ED50 of Esketamine for Laser Treatment in Children
Status:
NOT_YET_RECRUITING
Trial end date:
2025-04-27
Target enrollment:
Participant gender:
Summary
There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.